Société NuGenerex Immuno-Oncology, Inc.
Actions
NUGX
US67053X1028
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 6
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 01/01/17 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | - |
Eric von Hofe
PSD | President | 66 | - |
Jason Terrell
CTO | Chief Tech/Sci/R&D Officer | 43 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 18/01/17 |
Director/Board Member | 54 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marvin Hausman
BRD | Director/Board Member | 82 | - |
Brian T. McGee
BRD | Director/Board Member | 63 | - |
Carol A. Nacy
BRD | Director/Board Member | 76 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 18/01/17 |
Craig Eagle
BRD | Director/Board Member | 57 | - |
Joseph Moscato
CEO | Chief Executive Officer | 61 | 01/01/17 |
Director/Board Member | 54 | - | |
Thomas Leonard
BRD | Director/Board Member | 50 | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 101 196 670 | 33 149 554 ( 32,76 %) | 0 | 32,76 % |
Coordonnées société
NuGenerex Immuno-Oncology, Inc.
10102 USA Today Way Suite 200
33025, Miramar
+(416) 364-2551
http://www.nugenerexio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+16,61% | 122 Md | |
+17,75% | 112 Md | |
+17,23% | 25,91 Md | |
-24,11% | 19,33 Md | |
-18,56% | 16,17 Md | |
-18,47% | 15,56 Md | |
-47,75% | 14,65 Md | |
+57,35% | 14,34 Md | |
+5,62% | 14 Md |